Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China

被引:0
作者
Qianqian Zhang
Zheng Wang
Yanping Lv
Jiang Zhao
Qiang Dang
Dongfeng Xu
Dongxiang Zhao
Haiyang Liu
Ziqi Wang
Xingru Zhao
Zhiwei Xu
Xiaoju Zhang
机构
[1] Zhengzhou University People’s Hospital,Department of Respiratory and Critical Care Medicine
[2] Henan Provincial People’s Hospital,Department of Respiratory and Critical Care Medicine
[3] Zhoukou Central Hospital,Department of Respiratory and Critical Care Medicine
[4] Nanyang Central Hospital,Department of Respiratory and Critical Care Medicine
[5] The First Affiliated Hospital of Nanyang Medical College,Department of Respiratory and Critical Care Medicine
[6] Dengzhou Central Hospital,Clinical Research Service Center
[7] Henan Provincial People’s Hospital,undefined
[8] Zhengzhou University People’s Hospital,undefined
来源
Human Cell | 2021年 / 34卷
关键词
COVID-19; SARS-CoV-2; Ground glass opacity; Lymphopenia; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
Since December 2019, the novel coronavirus SARS-CoV-2 pandemic (COVID-19) outbroke in Wuhan and spread in China. Here we aimed to investigate the clinical and radiological characteristics of COVID-19 cases. We collected and analyzed the clinical data of 172 hospitalized cases of COVID-19 who were diagnosed via qRT-PCR of nasopharyngeal swabs during January 2020 and February 2020. The chest images were reviewed by radiologists and respirologists. The older patients with COVID-19 in Henan Province had more severe disease and worse prognosis. The male sex, smoking history and Wuhan exposure of patients are not related to the severity or prognosis of COVID-19. Family gatherings were showed among 26.7% of patients. A greater proportion of patients in the severe group suffer from combined chronic diseases. CT results showed that most patients had bilateral lung lesions and multiple lung lobes. The lungs of severe patients are more damaged. Both the infection range and inflammatory factor levels are related to the poor prognosis. Antiviral drugs, immunoglobulin and traditional Chinese medicine are mainly used for the treatment of COVID-19 patients. The discharge rate of COVID-19 patients was 93.0%, and the mortality rate was 2.3%. Case type, lymphocyte ratio grade, and respiratory failure at admission are risk factors for poor prognosis, except for the number of infiltrating lung lobes. The results showed that severe disease process, lymphopenia and respiratory failure are risk factors for the COVID-19.
引用
收藏
页码:419 / 435
页数:16
相关论文
共 148 条
  • [11] Zhou L(2020)A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Lancet 382 1177-481
  • [12] Tong Y(2020)SARS-CoV-2 viral load in upper respiratory specimens of infected patients N Engl J Med 8 475-146
  • [13] Zhu N(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 69 140-582
  • [14] Zhang D(2020)Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019-February 4, 2020 MMWR Morb Mortal Wkly Rep 7 4-2627
  • [15] Wang W(2020)A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Militar Med Res 172 577-234
  • [16] Li X(2020)Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2 Viruses 361 2619-1223
  • [17] Yang B(2020)The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application Ann Intern Med 10 232-251
  • [18] Song J(2009)Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States N Engl J Med 175 1219-269
  • [19] Chen N(2004)Secondary household transmission of SARS, Singapore Emerg Infect Dis 104 246-E114
  • [20] Zhou M(2006)Household transmission of SARS, 2003 CMAJ: Can Med Assoc J = Journal de l'Association Medicale Canadienne 368 m1091-250